Problems › Our Sales Cycle Is Too Long › Banks & Financial Services
Long cycles are usually the buyer failing to build an internal case, not the seller failing to persuade. This page works through it for banks and financial services firms specifically — including an unedited excerpt from a real analysis of a bank.
Long cycles are usually the buyer failing to build an internal case, not the seller failing to persuade. What makes this harder for banks and financial services firms is structural: the branch network is simultaneously the deposit moat and the cost problem — and the relationship knowledge sits in six people close to retirement. Any credible answer therefore has to hold efficiency ratio and cost of funds in the same view, which is exactly where most internal analysis stops because the two live in different systems.
A cycle that runs long is rarely stalled on interest. It is stalled at a specific point — a stage where the deal consistently sits — and that point is normally where the buyer has to justify the decision to somebody who was never in the room.
Which reframes the fix. Shortening a cycle is mostly a matter of giving the champion the material to win an argument you are not present for: the business case, the risk answer, the comparison against doing nothing.
The other frequent cause is selling to someone who cannot authorise the spend. That does not lengthen the cycle so much as add a hidden one at the end.
These three together are the signature. One on its own usually points somewhere else.
✓ Deals consistently stall at the same stage
✓ Forecast dates slip repeatedly on the same opportunities
✓ The main competitor in lost deals is no decision
The move that usually makes it worse. Adding follow-up activity, which increases pressure on the champion without giving them anything new to take to the decision-maker.
It is for you if you run or finance a bank and deals consistently stall at the same stage. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a bank. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Harborline Financial Group, a sample company profile used for testing rather than a customer — $3.1B commercial lending book, $410M of deposits.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Turn 71% of commercial borrowers into treasury customers at 65% contribution margin using existing branches and the 2027 core renewal.
The leak it closes. Reduces value transfer to fintech treasury platforms by locking 425 accounts into integrated deposit-lending workflow
The assumption it rests on. Core banking processor grants API depth at no incremental cost during 2027 renewal — the engine put the probability at 0.7.
| Investment required | $4–6M over 24 months ($2.5M technology integration, $1.5M 8 FTE hiring & training, $1M compliance & SOC-2 certification) |
| Expected return | 5.5× — $11M 5-year NPV on $5M investment |
| Revenue, year 1 | $0.45M incremental fee income (75 accounts × $4,200 × 65% margin × 6 months) |
| Revenue, year 2 | $1.79M incremental fee income (425 accounts × $4,200 × 65% margin) |
| Revenue, year 3 | $3.57M incremental fee income (850 accounts × $4,200 × 65% margin) |
| Exit criteria | Halt treasury build and reallocate remaining capital to SBA lending if (a) penetration <15% of overlap accounts by Month 18 OR (b) cumulative fee income < $800K by Month 18 OR (c) core-processor renewal does not include API depth clause by Month 6 |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Go-to-Market & Commercial Strategy, one of 29 engagements the platform runs. For banks and financial services firms it works through efficiency ratio, cost of funds, origination per banker and deposit concentration, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Find the stage where deals sit longest and work out what the buyer has to do there. It is almost always an internal approval, and the fix is material rather than persuasion.
It compresses the last step and does nothing to the stalls earlier in the cycle, which is where the time actually goes. It also teaches buyers that waiting is rewarded.
No, if the deal size and win rate justify it. It becomes a problem when the cycle is longer than your cash conversion allows, which is a financing constraint rather than a sales one.
Materially, yes. The branch network is simultaneously the deposit moat and the cost problem — and the relationship knowledge sits in six people close to retirement — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are efficiency ratio, cost of funds, origination per banker, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on efficiency ratio and cost of funds. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.